Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Orthofix Medical Inc. (OFIX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Visitors trend2W10W9M
22.53+0.16 (+0.72%)
At close: 04:00PM EST
22.15 -0.38 (-1.69%)
After hours: 04:45PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Commodity Channel Index

Commodity Channel Index

Performance Outlook
Previous Close22.37
Open22.17
Bid9.04 x 800
Ask24.00 x 800
Day's Range22.08 - 22.62
52 Week Range13.76 - 36.13
Volume284,784
Avg. Volume389,554
Market Cap804.977M
Beta (5Y Monthly)0.86
PE Ratio (TTM)N/A
EPS (TTM)-1.87
Earnings DateFeb 23, 2023 - Feb 27, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est37.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for OFIX

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Orthofix Medical Inc.
    OFIX: Raising target price to $23.00ORTHOFIX MEDICAL INC has an Investment Rating of HOLD; a target price of $23.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of High.
    Rating
    Fair Value
    Economic Moat
    3 days agoArgus Research
View more
  • Business Wire

    Orthofix Announces Full Commercial Launch and First Patient Cases of Mariner Deformity System

    LEWISVILLE, Texas, January 26, 2023--First product launch since the merger of Orthofix and SeaSpine; Mariner Deformity System addresses the complex requirements of adult deformity cases.

  • Insider Monkey

    15 Largest Orthopedic Companies in the World

    In this article, we will take a look at the 15 largest orthopedic companies in the world. If you want to see more companies in this selection, go to the 5 Largest Orthopedic Companies in the World. The orthopedic industry has staged a comeback in the last two years following a dismal 2020 due to […]

  • Business Wire

    Orthofix Medical Inc. Announces Preliminary SeaSpine and Orthofix 2022 Fourth Quarter and Full-Year Net Sales Results

    LEWISVILLE, Texas, January 09, 2023--(NASDAQ:OFIX) The merger of equals between Orthofix Medical Inc. ("Orthofix") and SeaSpine Holdings Corporation ("SeaSpine") became effective as of January 5, 2023. This news release includes the pre-merger unaudited preliminary net sales results of stand-alone SeaSpine and stand-alone Orthofix for the fourth quarter and full year ended December 31, 2022. As such, these preliminary financial results do not include any potential accounting adjustments that the

Advertisement
Advertisement